X4 Pharmaceuticals Inc (NASDAQ: XFOR) on Friday, soared 4.74% from the previous trading day, before settling in for the closing price of $3.8. Within the past 52 weeks, XFOR’s price has moved between $1.35 and $26.83.
Annual sales at Healthcare sector company grew by 47.41% over the past five years. The company achieved an average annual earnings per share of 63.60%. With a float of $78.31 million, this company’s outstanding shares have now reached $87.44 million.
X4 Pharmaceuticals Inc (XFOR) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of X4 Pharmaceuticals Inc is 10.44%, while institutional ownership is 32.31%. The most recent insider transaction that took place on Oct 23 ’25, was worth 249,997. In this transaction Executive Chairman of this company bought 86,206 shares at a rate of $2.90, taking the stock ownership to the 376,087 shares. Before that another transaction happened on May 16 ’25, when Company’s Chief Commercial Officer bought 1,032 for $2.48, making the entire transaction worth $2,561. This insider now owns 25,337 shares in total.
X4 Pharmaceuticals Inc (XFOR) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -6 earnings per share (EPS) for the period falling under the consensus outlook (set at -4.72) by -1.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.40% during the next five years compared to 47.41% growth over the previous five years of trading.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
X4 Pharmaceuticals Inc (XFOR) is currently performing well based on its current performance indicators. A quick ratio of 5.48 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.01, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.92 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
X4 Pharmaceuticals Inc (NASDAQ: XFOR) saw its 5-day average volume 0.82 million, a negative change from its year-to-date volume of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 67.65%.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 75.57%, which indicates a significant decrease from 91.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.27 in the past 14 days, which was lower than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.51, while its 200-day Moving Average is $4.28. Nevertheless, the first resistance level for the watch stands at $4.12 in the near term. At $4.25, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.43. If the price goes on to break the first support level at $3.80, it is likely to go to the next support level at $3.62. Assuming the price breaks the second support level, the third support level stands at $3.48.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
Market capitalization of the company is 348.00 million based on 87,437K outstanding shares. Right now, sales total 2,560 K and income totals -37,450 K. The company made 1,770 K in profit during its latest quarter, and -29,820 K in sales during its previous quarter.
